From ENDO 2021: Ushering in a New Era of Sustainable Weight Loss with Incretin-Based Therapies

Learn about the metabolic adaptations in obesity, the value of sustained weight loss, and the latest evidence for incretin-based therapies for long-term weight management.

Randy J. Seeley, PhD Jenny Tong, MD, MPH Kristina M. Utzschneider, MD Released: March 17, 2021

Here’s how I dose incretins and how I address potential GI adverse events, pancreatitis, and gallstones.

Kristina M. Utzschneider, MD Released: April 12, 2021

Read my answers to healthcare professionals’ questions about starting and stopping incretins in patients needing weight loss.

Jenny Tong, MD, MPH Released: May 4, 2021

Why I think set points are key to understanding weight and weight loss.

Randy J. Seeley, PhD Released: May 4, 2021

From ENDO 2021, expert faculty assess the metabolic adaptations in obesity, the value of sustained weight loss, and the latest evidence for incretin-based therapies for long-term weight management

Randy J. Seeley, PhD Jenny Tong, MD, MPH Kristina M. Utzschneider, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Registered Nurses: 1.5 Nursing contact hours Pharmacists: 1.5 contact hours (0.15 CEUs) Released: March 20, 2021 Expired: March 31, 2022